Gene: TMEM39B
Official Full Name: transmembrane protein 39Bprovided by HGNC
Gene Summary: Predicted to be located in endoplasmic reticulum membrane. Predicted to be active in membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO13324 | TMEM39B Knockout cell line (HeLa) | Human | TMEM39B | 1:3~1:6 | Negative | Online Inquiry |
KO13325 | TMEM39B Knockout cell line (HCT 116) | Human | TMEM39B | 1:2~1:4 | Negative | Online Inquiry |
KO13326 | TMEM39B Knockout cell line (HEK293) | Human | TMEM39B | 1:3~1:6 | Negative | Online Inquiry |
KO13327 | TMEM39B Knockout cell line (A549) | Human | TMEM39B | 1:3~1:4 | Negative | Online Inquiry |
TMEM39B Gene Knockout Cell Lines represent an advanced biotechnological tool specifically engineered for the in-depth study of the TMEM39B gene, which plays a critical role in cellular processes such as membrane trafficking and ion homeostasis. These cell lines are generated through CRISPR/Cas9 technology, ensuring precise gene disruption, allowing for the detailed exploration of the gene's biological functions.
The primary function of the TMEM39B Gene Knockout Cell Lines is to facilitate the elucidation of molecular pathways impacted by the absence of TMEM39B. By providing a controlled environment where researchers can directly observe the effects of gene knockout, these cell lines enable the investigation of mechanisms underlying various pathophysiological conditions, including neurodegenerative diseases and metabolic disorders.
The scientific importance of these cell lines is underscored by their potential applications in both basic research and clinical settings. They serve as powerful tools for gene function analysis, drug discovery, and the development of therapeutic interventions targeting TMEM39B-related pathways. Such insights can accelerate the identification of novel biomarkers and therapies, thus enhancing patient outcomes in disease contexts where TMEM39B is implicated.
Unlike conventional knockout models, TMEM39B Gene Knockout Cell Lines offer specific advantages such as rapid generation times, lower cost, and the ability to maintain homogeneity in cell population. This enables researchers to conduct high-throughput studies with reproducible results, streamlining the experimental process and enhancing data reliability.
For researchers and clinicians, the value of TMEM39B Gene Knockout Cell Lines lies in their ability to accelerate scientific discovery and clinical translation, thereby informing the development of innovative treatments. Moreover, our company has significant expertise in cellular and genetic engineering, backed by a commitment to high-quality products that serve the needs of the scientific community. With a focus on advancing research capabilities, our offerings empower scientists to push the boundaries of biological understanding.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.